Opioid Dispenser for Microdiscectomy/Laminectomy
Use of a Novel Device to Dispense Postoperative Opioids in Patients Undergoing Microdiscectomy/Laminectomy: A Pilot Study
1 other identifier
interventional
30
1 country
1
Brief Summary
The opioid crisis continues to plague the United States. While great strides have been made nationwide to decrease overprescribing, improvements are still needed to appropriately educate patients on the safe and responsible use, storage and disposal of opioids. Pain after surgery is often treated with opioid medications. Opioid medications can have side effects. Some side effects are relatively minor (constipation, nausea, vomiting), while others are more severe (sedation, abnormal breathing, etc.) and can lead to serious illness or death. Opioid pain medications when used the wrong way may also be addictive. Due to theses side effects, sometimes patients feel uncomfortable about taking these medications, and doctors prescribe them very cautiously. However, when used properly and safely, opioid pain medications are excellent pain relievers. Addinex, a technology company, has developed a device to help patients take opioids more safely. In this study the investigators aim to enroll a total of 30 patients who undergo spine surgery. Half will be randomly assigned to receive a standard pill bottle with opioids at discharge and will download a mobile app so that they can record their daily pain scores and the number of opioids they take for two weeks after surgery. The other half will receive the new opioid dispenser filled with opioids and a mobile app that generates a passcode that opens that device only at designated times. For this group of patients, every time the patient wants to take an opioid, they need to go to the app, enter their pain score before the app generates a passcode. The investigators will be tracking all study patients' opioid use and pain scores for the two weeks after surgery, will count how many pills they have left over 14 days after their surgery during a live telehealth session, and ask patients how they liked using the device. Results from this study will help understand if the Addinex device could potentially be useful to patients in the future after surgeries as opposed to typical pill bottles.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 5, 2024
CompletedFirst Posted
Study publicly available on registry
April 10, 2024
CompletedStudy Start
First participant enrolled
October 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
Study Completion
Last participant's last visit for all outcomes
December 1, 2026
December 8, 2025
November 1, 2025
Same day
April 5, 2024
December 2, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Cumulative Opioid Consumption at Postoperative Day 14 (POD14)
Cumulative Opioid Consumption at Postoperative Day 14 (POD14) following lumbar decompression (microdiscectomy/laminectomy), expressed as number of tablets and morphine equivalents (MED in mg) and collected via app starting at discharge to 14 days later.
Hospital Discharge to Postoperative Day 14
Secondary Outcomes (7)
NRS pain intensity ratings
PACU; Daily after Hospital Discharge: Postoperative Day 1 up to Postoperative Day 14
Patient satisfaction with the app and with the dispensing device
Postoperative Day 14
Frequency of reported difficulties using the device
Daily up to Postoperative Day 14
Frequency of reported difficulties using the app
Daily up to Postoperative Day 14
Opioid prescription refill rates
6 weeks postoperatively
- +2 more secondary outcomes
Study Arms (2)
Standard Opioid Pill Bottle with App
ACTIVE COMPARATOROpioid-Dispensing Device with App
EXPERIMENTALInterventions
Addinex Opioid-Dispensing Device
Addinex App
Eligibility Criteria
You may qualify if:
- opioid-naive patients or intermittent opioid users within 3 months of scheduled surgery
- At least 18 years old
- presenting for primary elective one-level lumbar laminectomy and/or discectomy via posterior approach with participating surgeon
- planned discharge on day of surgery/23 hour admission
- planned discharge to home
You may not qualify if:
- patients with opioid-tolerance
- patients without a smart-phone or without the ability to perform Telehealth visits
- patients unable to utilize the medication dispensing device
- patients presenting for other surgeries/surgeries with combined anterior/lateral approaches
- patient refusal
- allergy or intolerance to opioids
- planned admission after surgery
- planned discharge disposition to nursing facility or skilled rehabilitation
- planned use of or preference for opioid other than oxycodone
- patients who are pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital for Special Surgery
New York, New York, 10021, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vladimir Kramskiy, MD
Hospital for Special Surgery, New York
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 5, 2024
First Posted
April 10, 2024
Study Start (Estimated)
October 1, 2026
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
December 8, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Beginning 9 months and ending 36 months following article publication
- Access Criteria
- For researchers who provide a methodologically sound proposal and analyses to achieve aims in the approved proposal. Proposals should be directed to siderisa@hss.edu. To gain access, data requestors will need to sign a data access agreement.
Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices) will be shared.